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Key cellular functions including those related to energy metabolism, organization of the 
genetic information or production of membrane-bound and secreted proteins are 
compartmentalized within organelles. Various stresses such as differentiation programs, 
viral and bacterial infections, perturbations in protein production, mechanical constraints, 
changes in the environment and nutriment accessibility can impact cellular homeostasis 
and organelle integrity.  Perturbations of these cellular compartments trigger repair and 
adaptation programs aimed at restoring homeostasis. These events are often associated 
with low-grade inflammation also termed parainflammation. While the nature and 
mechanisms of danger-signals released by irremediably damaged cells are well understood, 
how transiently stressed cells trigger inflammation is still poorly understood. Emerging 
studies highlighted new mechanisms by which stress pathways promote inflammation. 
Cytosolic innate immune pathways are engaged by signals stemming from perturbed 
organelles such as the mitochondria, the endoplasmic reticulum (ER) or the nuclear 
envelope (NE). These observations indicate that these pathways function as guardians of 
cellular homeostasis and may contribute to disease in pathologies characterized by 
perturbations of cellular homoeostasis. Mitochondria stress, ER-stress or NE-stress are 
emerging as proinflammatory condition that contribute to human conditions and diseases. 





Innate immune systems have evolved to orchestrate immune responses in the context of infection 
and/ or injury.  Sensors have been developed to detect pathogens while other detect stress. Early 
studies in plants have shown that some innate immune receptors including those related to the 
NOD-like receptors (NLRs) can function as guardian of cellular integrity [1]. These sensors 
organize surveillance mechanisms that detect perturbations of cellular physiology leading to the 
activation of immune responses. This system contributes to immune reactions aimed at fighting 
infection, but it also plays an important role in repairing damaged tissues and the restoration of 
cellular homeostasis [2]. The response resulting from these sensors is aimed at protecting the 
organism and sustaining tissue repair. It contributes to the removing of cellular debris originated 
by dead cells and promotes cell proliferation [3]. Inability to repair or eliminate the insult, as 
well as deregulation of these stress-sensing mechanisms, can trigger a low-grade underlining 
inflammation also termed parainflammation [4]. This response has been proposed to contribute 
to various conditions, diseases and pathologies including metabolic disorders, cancer and aging 
[5]. Perturbations of cellular integrity can also contribute to inflammation in rheumatic diseases. 
For example in gout, large crystals of monosodium urate trigger membrane destabilization and a 
process termed “frustrated phagocytosis” that promotes cellular perturbations causing the 
activation of the inflammasome. 
Pathways and mechanisms monitoring the integrity of organelles such as the mitochondria, the 
endoplasmic reticulum (ER) and the nuclear envelope are emerging as central component of 
immune responses to cellular stress. In this review we will discuss recent advance identifying 
inflammatory signals stemming from these organelles, once stressed or damaged. 
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Stress signals 
In contrast to danger signals that are molecules and factors generally released by irremediably 
damaged cells, stress pathways and signals are produced by cells experiencing some sort of 
reversible loss of function. In this context the restoration of cellular function and homeostasis 
relies on an adaptation program that eliminates the insult and orchestrates the repair of the 
affected cellular compartment. As a result the inflammatory pathways originating form stressed 
organelle can be initiated by the active release of signals and factors as part of the adaptation 
response. Alternatively the release of these signals may directly result from the damage itself.  
Another major difference that distinguishes danger signals from stress signals, is the fact that 
stress signals can effectively trigger innate immune pathways directly from stressed cells in a 
cell-autonomous manner provided that these cells are intact and functioning. 
Mitochondria-stress mediated NLRP3 inflammasome activation  
Mitochondria are involved in wide-range of key cellular functions related to cellular metabolism 
and bioenergetics. These organelles function as metabolic hubs within the cell that can modify 
their physiology to meet cellular needs [6]. As part of the adaptation response, mitochondria can 
integrate intrinsic and extrinsic signals to adapt their function and number. Mitochondria can be 
targeted for destruction through mitophagy. This allows for example the elimination of damaged 
mitochondria. These organelles can also respond to stimuli and damage by actively releasing 
signals, including signals that modulate inflammatory pathways.  
The importance of mitochondria in innate immunity is exemplified by the fact that several innate 
immune pathways are assembled on mitochondria that provide proper localization to their 
corresponding signalosomes. The assembly at the mitochondria and subsequent oligomerization 
of MAVS (mitochondrial antiviral signaling protein) also known as CARDIF (CARD adaptor 
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inducing IFN-β) is essential for the engagement of type I interferon responses early following the 
detection of viral RNA within the cytosol of infected cells. Localization of the NLRP3 
inflammasome at the mitochondria has also been reported to be a key event leading to its 
activation [7, 8].  
Mitochondria are also participants in the initiation of innate immune signaling. Stressed 
mitochondria release inflammatory products that contribute to the engagement of inflammatory 
pathways. The best characterized one being the NLRP3 inflammasome (Figure 1).   
NLRP3 is a scaffold protein that upon activation oligomerizes and recruits the adaptor ASC and 
the protease caspase-1. Following initial recruitment within the inflammasome, ASC can further 
assemble into high-molecular weight complexes by a process that resembles “prion-like” 
polymerization [9]. This engages most ASC molecules present within the cytosol of the cell into 
one active complex that recruits and promotes the activation of caspase-1. Inflammation is then 
initiated by the proteolytic maturation and of the cytokines IL-1b and IL-18.  
Mitochondria are dynamic and continually change shape through the combined mechanisms of 
fission and fusion. Factor involved in mitochondrial dynamics have been found to impact 
NLRP3 activation. Decreased expression of the dynamin-related protein 1 (Drp1) triggers a 
defect in mitochondria fission that potentiates NLRP3 engagement [10]. In contrast, mitofusin-2 
a positive regulator of mitochondria fusion has been shown to participate in NLRP3 activation. 
NLRP3 inflammasome activation can also be impacted by factors that regulate the removal of 
damaged mitochondria via mitophagy. Sestrin-2 has been proposed to decrease NLRP3 
inflammasome assembly by promoting mitophagy [11]. Similarly, genetic defects in the 
autophagy machinery impacting on mitophagy have been found to contribute to inflammation in 
Crohn's disease [12]. 
 6 
Most described conditions and stimuli that trigger the NLRP3 inflammasome assembly and 
activation are characterized by perturbations of mitochondria homeostasis. It is likely that the 
release of mitochondria products function as signals leading to the engagement of NLRP3. The 
release of mitochondrial reactive oxygen species (mROS), and the release of mitochondrial DNA 
(mDNA) have been proposed to trigger NLRP3 activation [6, 13].  
The release of mROS has been involved in autoinflammatory diseases. For example, in TNFR1-
associated periodic syndrome (TRAPS) patients, mutations within the TNFR1 have been shown 
to promote the generation of mROS [14].  This could explain the contribution of IL-1b and the 
inflammasome in this disease  
The oxidized form of xanthine dehydrogenase, xanthine oxidase (XO) contribute to the 
formation of uric acid as well as mROS, Interestingly the inhibition of XO was shown to dampen 
inflammasome activation, suggesting that drugs used in gout to target XO and lower uric acid 
levels, may also impact mitochondria-triggered inflammation [15]. Whether these drugs could be 
of interest and repositioned in another autoinflammatory diseases such as TRAPS, is an 
hypothesis that remains to be tested. 
The mechanisms by which mROS and other factors, possibly released by the mitochondria, 
activate the NLRP3 inflammasome are still not completely understood. One possibility is that 
mROS directly activates NEK7, a member of the family of mammalian NIMA-related kinases 
(NEK proteins). NEK7 directly interacts with NLRP3 and was proposed to be the possible ligand 
linking stress signals to NLRP3 activation [16-18] (Figure 1). 
 
ER-stress mediated inflammasome activation 
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The endoplasmic reticulum (ER) is a continuous network of flattened sacs or tubes encased in 
membranes. Several metabolic pathways are compartmentalized within the ER. The synthesis, 
folding, maturation and transport of virtually all membrane and secreted proteins takes place in 
the ER. Hence, this organelle is the central compartment that produces most ligands and 
receptors involved in cell-cell communication. The ER harbors well-characterized sensors that 
control its capacity to meet the fluctuations in demand for protein synthesis and restore 
homeostasis if the organelle is overloaded or damaged [19]. ER-stress is a hallmark that has been 
associated with various rheumatic diseases including rheumatoid arthritis and spondyloarthritis 
(for review see [20]), however the mechanisms linking ER-perturbations and inflammation are 
still poorly understood.  
Initial studies have shown that the inflammatory caspases, caspase-12 and the human homologue 
caspase-4 were activated in conditions of ER-stress [21]. While the roles of these proteases in the 
context of ER-stress are still unknown or controversial, these early observations indicated the 
possibility that ER-stress may contribute to inflammation-related pathways [22]. Several studies 
provided evidences that the NLRP3 inflammasome could be involved in caspase-1 activation in 
the context of ER-stress. It was shown that treatment of macrophages with compounds that 
disrupt ER function such as thapsigargin and tunicamycin trigger inflammasome-dependent IL-
1b secretion [23] (Figure 2). ER-stress was found to initiates an hepatic NLRP3 inflammasome 
activation that triggers inflammation-mediated liver injury in chronic liver diseases [24]. Two 
other studies have suggested that ER-stress may promote inflammasome activation by mediating 
the up-regulation of the NLRP3 binding protein TXNIP in insulin-producing b-cells [25, 26]. 
How TXNIP may regulate NLRP3 upon ER-stress is still unclear and awaits further studies.  
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The adaptation to ER-stress is mediated by several membrane-bound stress sensors that detect 
perturbations within the ER lumen. Among these sensors, IRE1, is particularly well studied [19]. 
In the context of microbial infection with the Brucella abortus vaccine strain RB51, it was 
shown that ER-stress mediated IRE1 activation engages NLRP3 at the mitochondria. This 
triggers an amplification-loop that augments the release of mitochondrial signals such as mROS 
further increasing NLRP3 activation [27].  These findings suggest that ER-stress may target the 
mitochondria to promote inflammasome activation.  
The relevance of the IRE1-inflammasome connection was also described in a model of 
atherosclerosis. IRE1 function is mediated by its ribnonuclease activity. In macrophages, 
inhibitors targeting its ability to cleave RNA molecules reduce inflammasome activation 
mediated by hyperlipidemia-induced ER stress [28]. Moreover, in mice, IRE1 inhibitors 
decreased lipid-induced IL-1β and IL-18 production in the serum and reduced atherosclerotic 
plaque size [29]. 
IRE1-mediated activation of XBP1 and RIG-I  
Activation of the innate immune receptors TLR2 and TLR4 by their respective ligands has been 
shown to activate the ER stress response proteins IRE1. This promotes the activation of the 
downstream active transcription factor XBP1 and was found to enhance the secretion of 
inflammatory cytokines such as IL-6 by macrophages [30]. These findings indicate that ER-
stress signaling pathways exacerbate the transcription of pro-inflammatory programs. Such 
response could be particularly relevant in stressed tissues exposed to microbial products and 
could lead to the production of an hyper responsive TLR response.  
ER-stress mediated IRE1 activation has also been linked to the activation of the RIG-I pathway 
(Figure 2). RIG-I is a member of a family of cytosolic innate immune receptors termed RIG-I 
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like receptors (RLRs). RLRs are DExD/H box RNA helicases that detect viral RNA ligands or 
processed self-mRNA in the cytoplasm. Upon activation, these sensors activate transcriptional 
programs with a type I interferon and NFkB signatures, thus promoting innate immunity and 
inflammation. Activation of IRE1 is involved in the degradation of specific cellular mRNA by a 
mechanism referred to as regulated IRE1-dependent decay (RIDD). This cleavage generates 
specific modifications within the RNA degradation products. In fact RIDD products are single 
stranded 5’-OH and 2’-3’-cyclic phosphate mRNA fragments.  It was shown that these mRNAs 
are then detected by RIG-I, leading to the activation of a RIG-I dependent immune response. 
This was shown for example in the context of ER-stress pathways initiated by bacterial toxins 
such as Cholera and Shiga toxins. These microbial factors have been shown to elicit the IRE1-
RIG-I response in order to amplify immune responses [31]. This pathway also been involved in 
trichohepatoenteric syndrome, a systemic interferonopathy, associated with deficiency in TTC37 
and SKIV2L [32]. The products of these two genes are cytosolic proteins involved in the 
degradation of cellular mRNA and may contribute to the elimination of cytosolic amounts of 
RIDD products produced by ER-stress responses. Therefore, inflammation in these patients is 
probably caused by SKIV2L (and possibly TTC37) deficient removal ER-stress mediated RIDD 
products [32].  
ER-stress mediated NOD1 and NOD2 activation  
ER-stress has also been involved in the activation of the innate immune sensors NOD1 and 
NOD2 [33]. These proteins are cytosolic members of the intracellular NOD-like receptor family 
that function to promote host defenses against bacteria through the induction of inflammation 
and immune responses [34]. NOD1 and NOD2 typically detect pathogen associated molecular 
patterns (PAMPs). NOD1 is activated by a motif present in many Gram-negative bacteria and 
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certain Gram-positive bacteria, whereas NOD2 senses a conserved peptidoglycan product 
ubiquitously present in bacteria. A recent report showed that the ER-stress inducers thapsigargin 
and dithiothreitol trigger the production of the cytokine IL-6 in a manner that relies on both 
NOD1 and NOD2 [33]. In this study it was found that mice infected with Brucella abortus 
elicited a proinflammatory responses that was reduced by NODs deficiency or upon treatment 
with the ER-stress inhibitor TUDCA. Similarly the response was blunted upon treatment with the 
IRE1 inhibitor KIRA6 indicating that IRE1 may link ER-stress to NODs activation. Overall 
these findings suggest that NOD proteins drive inflammatory pathways engaged by ER-stress. 
However the mechanisms by which IRE1 may directly activate NODs, the signals detected by 
NODs during ER-stress and the physiological relevance of this response in other ER-stressed 
tissues and ER-stress associated pathologies remain to be investigated.  
NE-stress mediated activation of the AIM2 inflammasome  
The nuclear envelope (NE) is a highly regulated membrane barrier that physically separates the 
nucleus and its content from the cytoplasm [35]. The nuclear envelope inner and outer 
membranes are continuous with the ER. However, despite this continuity, both the NE and ER 
membranes are comprised of specific proteins that fulfill distinct functions and make the NE and 
ER distinct compartments.  
Transient alterations of nuclear envelope homeostasis is characteristic of different pathologies, 
including viral infections, laminopathies and cancer [36, 37]. For example, infection with HIV 
can provoke nuclear envelope instability characterized by prominent lamina gaps as well as large 
blebs of herniating chromatin resulting in the exposure of nuclear material within the cytoplasm 
[38]. Transient nuclear rupture is also a hallmark of cultured fibroblasts from laminopathy 
patients [39]. These patients have inherited mutations that impair the maturation of lamin A, a 
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structural component of the nuclear lamina. As a consequence, discontinuities of nuclear 
envelope was observed in hearts of mutant mice deleted for lysine 32 of lamin A [40] and in the 
liver of lamin A deficient animals [41]. Cancer cells also often exhibit changes in lamin A 
expression and nuclear morphology that resembles the phenotype observed in laminopathies, 
indicating that cancer cells may experience transient nuclear envelope rupturing [42, 43].  
Importantly the NE envelope rupture is not a definitive event that results allways in the 
elimination of damaged cells. The NE is able to repair. This was observed in setups using 
pipettes to pass the NE for direct nuclear injections of DNA. It was also suggested from 
observations in the context of viral infections and laminopathies, however the mechanism 
involved in NE repair and the exact nature of the NE-stress response pathways are largely 
unknown [37, 39]. Recent work uncovered quality control mechanisms that cope with damage of 
nuclear envelope proteins and ensure the integrity of the nuclear envelope membranes [44]. This 
further demonstrates that similar the ER, the NE hosts adaptation programs that ensure its 
integrity. Importantly, the concept of NE-stress responses was demonstrated experimentally; 
cancer cells and immune cells forced to squeeze through tiny pores were found to undergo 
repeated rupturing the nuclear envelope that was followed by repair and restoration of cellular 
homeostasis [45, 46], further indicating that a NE response is a significant cellular phenomenon 
that is possibly relevant to physiological processes and several diseases.   
Recently using a pharmacological perturbation of the nuclear envelope structure it was found 
that NE-stress and transient membrane rupture engages cytosolic innate immune receptors [47]. 
In this study the anti-viral drug nelfinavir was found to inhibit lamin A maturation causing 
alterations of nuclear shapes and transient exchange of material between the nucleus and the 
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cytoplasm. This promotes the exposure in the cytoplasm of nuclear DNA, therefore triggering 
the activation of cytosolic sensors of DNA such as cGAS and AIM2 [47](Figure 3).  
AIM2 harbors a DNA-binding region that is known to detect the cytosolic release of microbial 
double-stranded. This triggers AIM2 oligomerization and the assembly of an inflammasome 
harboring the adaptor ASC and the protease caspase-1. Transfection experiments have indicated 
that AIM2 detects dsDNA in a sequence-independent manner and from virtually any origin, 
including pathogen of any type and mammalian DNA [48]. AIM2 detection of self-DNA has 
been proposed to contribute to inflammation is diseases. For example, it was shown that AIM2-
dependent release of IL-1b in the skin may contribute to psoriasis [49]. 
Similarly to AIM2, the cGAS-STING pathway was found to be activated upon transient rupture 
of the nuclear envelope [47]. The ER-localized protein STING (stimulator of IFN genes) is 
essential for IFN-b production in response to a variety of DNA stimuli of bacterial, viral, 
parasitic, or synthetic origin. A key signaling pathway upstream of STING involves the cGAMP 
synthase (cGAS). Cyclic-GMP-AMP (cGAMP) is produced by cGAS upon detection of DNA. 
This molecule, then, directly interacts with STING leading to the activation of proinflammatory 
transcriptional program related to a typical type I interferon gene signature.  
These observations suggest that NE-stress and associated inflammatory pathways could 
contribute to conditions and disease associated with transient NE rupture such as laminopathies 
and cancers, however the physiological importance of this model remain to be tested.  
Conclusions  
The emerging concept that stress pathways can initiate inflammatory responses has open several 
new avenues of research. The mechanisms linking stress signals to the innate immune machinery 
are still poorly understood. Identifying these mechanisms will provide further insight on the 
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evolutionary roots of this sophisticated system. In particular it would of interest to identify how 
the different stress responses co-operate to orchestrate various responses. It appears that signals 
stemming from the ER co-operate with the mitochondria to activate the NLRP3 inflammasome. 
It is likely that other organelles may co-operate. The NE may communicate with the RE to 
mount the NE stress-adaptation response and possibly to modulate inflammatory pathways. 
Finally, while organelles stress is a hallmark of several diseases and conditions, the precise role 
of the resulting stress-associated inflammation in these diseases is still poorly understood. 
Deciphering these connections will provide new therapeutic targets to modulate stress pathways 
and inflammation in diseases and conditions characterized by ER-stress and inflammation such 
as laminopathies, obesity, cancer and aging.  
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Figure 1 Mitochondria role in the activation of the NLRP3 inflammasome 
NLRP3 activating signals such as extracellular ATP or monosodium urate crystals signal via 
specific receptors or via interactions with the plasma membrane. This promotes a cellular 
response that includes potassium efflux through ion channels, and mitochondrial perturbations 
leading to the production and release of mitochondrial DNA and mitochondrial ROS (mROS) 
into the cytosol. mROS possibly in combination with other released factors engages NLRP3 
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activating factors such as NEK7, thereby promoting inflammasome assembly. The adaptor ASC 
is recruited to the NLRP3 inflammasome and nucleates into prion-like filaments. ASC recruits 
Caspase-1 and oligomerizes off the ASC filaments leading to its activation. Active caspase-1 
promotes the proteolytic cleavage and maturation of proIL-1b into the biologically active IL-1b 
hence, initiating an inflammatory cascade. 
Figure 2 Inflammatory pathways triggered by endoplasmic reticulum stress 
ER-stress triggers the activation of the endoribonuclease IRE1. This promotes the activation of 
the transcription factor XBP1 that can stimulate cytokine production and exacerbate 
inflammatory responses. IRE1 activation can also lead to the activation of the NLR proteins 
NOD1 and NOD2. This triggers the kinase RIPK2 that promotes the activation of the pro-
inflammatory transcription factor NFkB. IRE1 can engage the degradation of a specific mRNA 
pool by a process called IRE1-dependent decay of mRNA (RIDD). RIDD degradation products 
are recognized by the RLR sensor RIG-I leading to the activation of a MAVS dependent 
proinflammatory response. Finally IRE1 activation has also been proposed to induce NLRP3 
translocation to the mitochondria leading to mitochondrial damage and release of NLRP3 
activating signals, thereby promoting inflammasome activation and IL-1b secretion.  
 
Figure 3 Inflammasome activation upon destabilization of the nuclear envelope 
Perturbations in the maturation of the Lamin A triggers transient alterations of NE structures and 
causes the transient exposure of self-DNA. Released DNA is detected by AIM2 leading to the 
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